The contribution of comorbidities to mortality in hospitalized patients with heart failure
- 125 Downloads
Heart failure (HF) with reduced ejection fraction (HFrEF) has a worse prognosis than HF with preserved EF (HFpEF). The study aimed to evaluate whether different comorbidity profiles of HFrEF- and HFpEF-patients or HF-specific mechanisms contribute to a greater extent to this difference.
We linked data from two health insurances to data from a cardiology clinic hospital information system. Patients with a hospitalization with HF in 2005–2011, categorized as HFrEF (EF < 45%) or HFpEF (EF ≥ 45%), were propensity score (PS) matched to controls without HF on comorbidites and medication to assure similar comorbidity profiles of patients and their respective controls. The balance of the covariates in patients and controls was compared via the standardized difference (SDiff). Age-standardized 1-year mortality rates (MR) with 95% confidence intervals (CI) were calculated.
777 HFrEF-patients (1135 HFpEF-patients) were PS-matched to 3446 (4832) controls. Balance between patients and controls was largely achieved with a SDiff < 0.1 on most variables considered. The age-standardized 1-year MRs per 1000 persons in HFrEF-patients and controls were 267.8 (95% CI 175.9–359.8) and 86.1 (95% CI 70.0–102.3). MRs in HFpEF-patients and controls were 166.2 (95% CI 101.5–230.9) and 61.5 (95% CI 52.9–70.1). Thus, differences in MRs between patients and their controls were higher for HFrEF (181.7) than for HFpEF (104.7).
Given the similar comorbidity profiles between HF-patients and controls, the higher difference in mortality rates between HFrEF-patients and controls points more to HF-specific mechanisms for these patients, whereas for HFpEF-patients a higher contribution of comorbidity is suggested by our results.
KeywordsHeart failure Mortality Claims data Comorbidities
The authors are grateful to the statutory health insurances AOK Bremen/Bremerhaven and AOK Niedersachsen for contributing data to the study. This study was supported by Bayer AG, Germany.
Compliance with ethical standards
Conflict of interest
A Michel and D Vizcaya are full-time employees of Bayer AG. J. Berg is a full-time employee of the statutory health insurance AOK Bremen/Bremerhaven. S. Eberhard is full-time employee of the statutory health insurance AOK Niedersachsen. O. Riedel, D. Enders, N. Schlothauer, A. Elsässer and C. Ohlmeier have nothing to disclose.
- 9.in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review. Eur J Heart Fail 18: 54–65Google Scholar
- 14.Yancy CW, Lopatin M, Stevenson LW et al (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function—a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database. J Am Coll Cardiol 47:76–84CrossRefPubMedGoogle Scholar
- 24.Parsons L (2001) Reducing bias in a propensity score matched-pair sample using greedy matching techniques. SUGI26. Paper 214–26Google Scholar
- 25.Chiang C (1967) Standard error of the age-adjusted death rate. Vital Statistics—Special Reports, Selected Studies 47Google Scholar
- 28.Centres for Medicare & Medicaid Services (2012) Chronic conditions among medicare benificiaries—Chartboo, 2012 Edition. Centes for Medicare & Medicaid Services, BaltimoreGoogle Scholar
- 37.Chang HJ, Chen PC, Yang CC, Su YC, Lee CC (2016) Comparison of Elixhauser and Charlson methods for predicting oral cancer survival. Medicine 95Google Scholar
- 38.Li B, Evans D, Faris P, Dean S, Quan H (2008) Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res 8Google Scholar